Sponastrime dysplasia
A rare genetic disorder affecting bone development
Sponastrime dysplasia is a rare genetic disorder characterized by abnormal bone development, leading to dwarfism and other skeletal anomalies. It is inherited in an autosomal recessive pattern.
Genetics[edit | edit source]
Sponastrime dysplasia is caused by mutations in specific genes that are involved in the development and maintenance of cartilage and bone. The disorder follows an autosomal recessive inheritance pattern, meaning that an affected individual must inherit two copies of the mutated gene, one from each parent. Parents of an affected individual are typically carriers, possessing one copy of the mutated gene but not exhibiting any symptoms themselves.
Clinical Features[edit | edit source]
Individuals with sponastrime dysplasia typically present with short stature due to disproportionate shortening of the limbs. Other common features include:
- Scoliosis
- Kyphosis
- Platyspondyly (flattened vertebrae)
- Metaphyseal dysplasia
- Joint laxity
Facial features may include a prominent forehead, depressed nasal bridge, and midface hypoplasia.
Diagnosis[edit | edit source]
Diagnosis of sponastrime dysplasia is based on clinical evaluation, family history, and radiographic findings. X-rays typically reveal characteristic skeletal abnormalities such as platyspondyly and metaphyseal changes. Genetic testing can confirm the diagnosis by identifying mutations in the associated genes.
Management[edit | edit source]
There is no cure for sponastrime dysplasia, and management focuses on addressing symptoms and improving quality of life. This may include:
- Physical therapy to improve mobility and strength
- Orthopedic surgery to correct skeletal deformities
- Regular monitoring for complications such as spinal stenosis
Prognosis[edit | edit source]
The prognosis for individuals with sponastrime dysplasia varies depending on the severity of the skeletal abnormalities and associated complications. With appropriate management, many individuals can lead active lives.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD